International Patent: COMPOUND HAVING NOVEL STRUCTURE AS UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

GENEVA, July 2 -- CHONG KUN DANG PHARMACEUTICAL CORP. filed a patent application (IB2025/063028) for “COMPOUND HAVING NOVEL STRUCTURE AS UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME”. With publication no. WO/2026/133173, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 471/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....